SOX2 and neoplasm: Our discovery that enhancers involved in the development of the digestive and respiratory systems are reprogrammed to support SOX2 up-regulation during tumorigenesis is in line with previous observations that tumor-initiating cells acquire a less differentiated phenotype (143–146).